[Reblog] Precision Medicine Initiative: Some quick resources
From the 30 January 2015 post BY at Covering Health – Monitoring the Pulse of Healthcare Journalism
White House has announced its anticipated “Precision Medicine Initiative,” which it describes as an “emerging field of medicine that takes into account individual differences in people’s genes, microbiomes, environments, and lifestyles – making possible more effective, targeted treatments for diseases like cancer and diabetes. ”
….
The practice of medicine has always been personal regarding the treatment of individual patients, but science has fostered a new era of so-called personalized medicine that takes into account each person’s specific clinical, genetic, genomic and environmental information in designing tailored treatment plans
…
The White House released this fact sheet today.
This interview with the director of the program in personalized health at the University of Utah offers a good explanation of what personalized care is and examples of what it could do.
For Science magazine, Jocelyn Kaiser writes that the Obama precision medicine plan would create huge U.S. genetic biobank. She follows up with more details about the price tag and budget.
…
The White House released this fact sheet today.
This interview with the director of the program in personalized health at the University of Utah offers a good explanation of what personalized care is and examples of what it could do.
For Science magazine, Jocelyn Kaiser writes that the Obama precision medicine plan would create huge U.S. genetic biobank. She follows up with more details about the price tag and budget.
Related articles
- Five Accelerants to the Adoption of Connected Health (From the 28 January 2015 item at The cHealth blog)
“I have been thinking lately about the cultural and business phenomena that are currently shaping and accelerating the adoption of connected health and, in that context, came up with five accelerants. The best part of the story is that four of the five are already going on and we can see their early-stage effects.
So, at the risk of ‘dumbing down’ adoption, here is my list of five accelerants. If we could make these go faster, the adoption of connected health would accelerate too.”
1. Increase value-based reimbursement for providers.
2. Create more mechanisms for provider reimbursement for non face-to-face care (like the new CMS CPT code that just took effect).
3. Accelerate consumer choice in the marketplace as well as ‘consumer-driven health care’ (i.e., high deductible plans, health savings accounts (HSAs), etc.).
4. Make the consumer-facing technology truly frictionless.
5. Create a universal privacy/security technology and make it a public good.
-
Integrated approach to customer relationship management and patient relationship management (From the 28 January 2015 post at Health Care Conversation)
A comprehensive consumer and patient engagement model should help providers attract and engage individuals in the key areas they value:
- Help in understanding and navigating the health care system
- Personalize information and care based on an individual’s needs
- Easy access and communication with provider and care team
- Support in managing an acute episode or a chronic illness
- Secure access to personal health records
Related articles
[Press release] Chemists find a way to unboil egg whites: Ability to quickly restore molecular proteins could slash biotechnology costs
From the 23 January 2015 University of California- Irvine press release
UC Irvine and Australian chemists have figured out how to unboil egg whites – an innovation that could dramatically reduce costs for cancer treatments, food production and other segments of the $160 billion global biotechnology industry, according to findings published today in the journal ChemBioChem.
Chemistry major Stephan Kudlacek and professor Greg Weiss have developed a way of unboiling a hen egg.
Credit: Steve Zylius / UC Irvine“Yes, we have invented a way to unboil a hen egg,” said Gregory Weiss, UCI professor of chemistry and molecular biology & biochemistry. “In our paper, we describe a device for pulling apart tangled proteins and allowing them to refold. We start with egg whites boiled for 20 minutes at 90 degrees Celsius and return a key protein in the egg to working order.”
Like many researchers, he has struggled to efficiently produce or recycle valuable molecular proteins that have a wide range of applications but which frequently “misfold” into structurally incorrect shapes when they are formed, rendering them useless.
“It’s not so much that we’re interested in processing the eggs; that’s just demonstrating how powerful this process is,” Weiss said. “The real problem is there are lots of cases of gummy proteins that you spend way too much time scraping off your test tubes, and you want some means of recovering that material.”
But older methods are expensive and time-consuming: The equivalent of dialysis at the molecular level must be done for about four days. “The new process takes minutes,” Weiss noted. “It speeds things up by a factor of thousands.”
To re-create a clear protein known as lysozyme once an egg has been boiled, he and his colleagues add a urea substance that chews away at the whites, liquefying the solid material. That’s half the process; at the molecular level, protein bits are still balled up into unusable masses. The scientists then employ a vortex fluid device, a high-powered machine designed by Professor Colin Raston’s laboratory at South Australia’s Flinders University. Shear stress within thin, microfluidic films is applied to those tiny pieces, forcing them back into untangled, proper form.
“This method … could transform industrial and research production of proteins,” the researchers write in ChemBioChem.
For example, pharmaceutical companies currently create cancer antibodies in expensive hamster ovary cells that do not often misfold proteins. The ability to quickly and cheaply re-form common proteins from yeast or E. coli bacteria could potentially streamline protein manufacturing and make cancer treatments more affordable. Industrial cheese makers, farmers and others who use recombinant proteins could also achieve more bang for their buck.
UCI has filed for a patent on the work, and its Office of Technology Alliances is working with interested commercial partners.
Related articles
Advances in Cancer 2012
From the 28 December 2012 article by at The Health Care Blog
The 30,000 member American Society of Clinical Oncology is the world’s leading group of cancer physicians. ASCO is dedicated to curing cancer, supporting research, quality care, reducing treatment disparities and a heightened national focus on value. This month they released their annual Report on Progress Against Cancer, which highlights research, drug development and cancer care innovations. This hundred-page document is important reading for anyone who wants to be up-to-date regarding cancer care.
Cancer related deaths in the United States are dropping, but still totaled 577,000 in 2012. While world cancer research funding is rising, in the USA it continues to decrease, with the purchasing power of the largest funding source, the National Cancer Institute, having fallen 20% in the last decade, and a further 8% cut slated for January 1, 2013. Development is dependent on government and private funding, as well as the willingness of more than 25,000 patients a year who volunteer to be involved in cancer trials. All these critical supports are threatened. The Federal Clinical Trials Cooperative of the National Cancer Institute (FCLC, NCI) supports research at 3100 institutions in the USA.
The report discusses the many types of cancer which continue to be naturally resistant to cancer treatment, particularly chemotherapy. In some cases, drugs do not penetrate a part of the body, such as the brain, in other cases even when they reach the tumor, they are not effective. ..
Related articles
- Cancer Screening Rates Have Fallen In US (medicalnewstoday.com)
- A Look At Childhood Cancer And African Americans (sys-con.com)